Literature DB >> 11916071

Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.

Joseph D Mills1, Michael W Mansfield, Peter J Grant.   

Abstract

We aimed to investigate whether increased levels of FXIII and/or a low prevalence of the protective Leu allele (of the Val34Leu FXIII polymorphism) occur in relatives of patients with severe CAD. 185 healthy male relatives aged 65 or less were recruited from 125 patients with multi-vessel CAD and compared to 185 healthy, age-matched controls. The relatives and controls were similar in terms of clinical parameters. FXIII B-subunit levels were elevated in relatives, 1.11 microg/mL (1.08-1.14), compared with controls, 1.00 microg/mL (0.97-1.04), P <0.0001 but FXIII A2B2 levels did not differ between the groups. There was a strong correlation between FXIII B-subunit and the insulin resistance syndrome, however, adjusted B-subunit levels remained significantly higher in relatives. There was no difference in genotype frequency at the FXIII Val34Leu polymorphism between relatives and controls. FXIII B-subunit levels are elevated in the relatives of CAD patients and this is independent of other cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916071

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

Review 1.  Not all clots are created equal: a review of deficient thrombolysis with tissue plasminogen activator (tPA) in patients with metabolic syndrome.

Authors:  Charles I Mosimah; Pamela J Murray; James W Simpkins
Journal:  Int J Neurosci       Date:  2018-12-27       Impact factor: 2.292

2.  Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population.

Authors:  Manopriya Thiruvagounder; Shaheen Khan; Dhastagir S Sheriff
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

Review 3.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.